Commercial Use Pharmaceutical Processing Machine Capsule Sizes Capsule Filling Machine for Industrial

Name: Commercial Use Pharmaceutical Processing Machine Capsule Sizes Capsule Filling Machine for Industrial
Brand: Jining Factop International Trade Co., Ltd.
SKU: 2195910272

Shandong, ChinaJining Factop International Trade Co., Ltd.

US$5,000.00

1 Set

Product profile

Customization

Available

After-sales Service

Engineers Available to Service Machinery Overseas, Free Spare Parts, Online Support,video Technical Support

Certification

CE, FDA, GMP

Model NO.

Capsule filling line

Condition

New

Customized

Fill Range

≤49ml

Filling Principle

Auger Filling

Machine Type

Capsule Filling Machine

Main Material

Stainless Steel

Voltage

220V

Warranty

Full Life

Standard

GMP

Material

Contact SS304/316

Finished Product

Tablet/Capsule

Speed

Adjustment

Field

Pharmacy, Medical, Food

Applicable

Health Product Factories

Packing Type

Bottle

Transport Package

Export Wooden

Specification

1400kg

Trademark

Origin

China

HS Code

8479899990

Production Capacity

500 Set/Week

Key features

Compliant with GMP standards, clean and corrosion-resistant, suitable for pharmaceutical production standards

Integrated complete set of equipment, fully automated from granulation to tablet forming

Low operating energy consumption, easy operation and maintenance, excellent mass production efficiency

Company profile

Importers and ExportersHigh Repeat Buyers ChoiceFast DeliveryMinor Customization

Jining Factop International Trade Co., Ltd.

Shandong, China

Business Type: Manufacturer/Factory, Trading CompanyExport Year: 2014-06-20Nearest Port: Shanghai, NingboAverage Response Time: ≤0.83hTerms of Payment: T/T, Western Union, Money GramInternational Commercial Terms(Incoterms): FOB, EXW, CFR, CIF, DDP, DAP, FCA

AI-Powered supplier vetting

SummaryThe supplier manufactures pharmaceutical and packaging machinery, including blister packing, sugar coating, tablet counting, and related production equipment. Its products are exported to the United States, Europe, the Middle East, Southeast Asia, and North America, with exports representing 51%–70% of total sales and eight years of exporting experience. Production and delivery indicators are partially positive, including peak- and off-season lead times within 15 workdays and stated quality assurance with raw-material traceability. However, the supplier has no documented corrective-action or complaint-handling procedures, no supplier-service assessment records, no listed management-system certification, no overseas service infrastructure, no inventory service capability, and no new products launched during the previous year. R&D and design resources appear limited, with one R&D engineer and minor customization capability. Customer retention is reported at 50%–80%, but specific customer cases are not provided.

Supplier typeThe supplier is a manufacturer and developer of pharmaceutical production and packaging machinery, including blister packing, sugar coating, tablet counting, and powder-to-tablet/capsule equipment. It sells domestically and exports to the United States, Europe, the Middle East, Southeast Asia, and North America, with eight years of export experience and stated self-operated import/export rights.

CertificationsThe supplier states that its tablet-press digital control system supports alignment with cGMP and FDA requirements, but the available information does not identify a certification held by the supplier. Supplier management-system certification is explicitly listed as NIL, so no formal certification holding is evidenced.

After-Sales capabilityThe supplier cites good after-sales service as a company tenet and accepts multiple quotation terms, but it has no written corrective/preventive-action procedures, no written customer-complaint procedures or records, and no written service-capability assessment procedure. It also reports no overseas agents or branches, overseas warehouse, showroom, inventory capability, or overseas service countries, indicating limited documented and local service infrastructure.

R&D capabilityThe supplier reports integrated development and production capabilities and describes high-tech machinery development, but it has only one R&D engineer, one year of total R&D-engineer experience is reported, and no new products were launched during the previous year. These explicit indicators show limited recent innovation output.

Production capacityThe supplier reports integrated manufacturing of several pharmaceutical machinery categories, exports representing 51%–70% of sales, annual production output above the stated threshold, and lead times within 15 workdays in both peak and off-season periods. Quality assurance and raw-material traceability are reported, although finished products are randomly inspected and checked by packing staff, which limits the evidence of a robust final-inspection system.

Customization capabilityThe supplier explicitly offers minor customization. No evidence is provided of moderate or extensive engineering customization, so the demonstrated capability is limited to minor modifications.